Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
In the SURMOUNT trial (for obese or overweight non-diabetic patients), the average weight loss of patients in the high-dose (15mg) group was 20.9%, with a weight loss of approximately 22.5 kg
Patients had a mean age of 48 years (range: 20 to 76 years), 67% were male, 66% were White, 20% were Asian, 8% were American Indian/Alaska Native, and 6% were Black or African American
Planning for after tirzepatide This is something most providers do not talk about enough
Summary and Clinical Pearls PT-141 (Bremelanotide Acetate) offers a unique therapeutic option for managing sexual dysfunction through central nervous system modulation of libido pathways
Clinical Trials and Research on Compounded Tirzepatide Numerous clinical trials have been conducted to evaluate the safety and efficacy of compounded Tirzepatide
US$ 23.53
US$ 20.05
US$ 22.34
US$ 26.92
US$ 26.90
US$ 26.77
US$ 21.72
US$ 25.88
US$ 27.62
US$ 26.43
